Renalytix
Steven Coca is a Professor and Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai, a position held since October 2014. Additionally, Steven Coca is a Co-Founder of Renalytix, contributing to the company since November 2018.
This person is not in any teams
Renalytix
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.